Cycle Pharmaceuticals launches free trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ dietary needs

By |2021-05-17T18:52:31+01:00November 10th, 2017|News, Nityr|

Cycle Pharmaceuticals Receives FDA Approval of Nityr™ (nitisinone) Tablets for Treatment of HT-1

By |2021-05-17T18:52:31+01:00August 1st, 2017|News, Nityr|

First recommendation for HT-1 treatment in Quebec by INESSS

By |2021-05-17T18:52:31+01:00June 2nd, 2017|News|
Go to Top